Study on ~(99M)tc-Trodat-1 SPECT in Diagnosis of Early Parkinson's Disease

Chengchuan Jiang

2002-01-01

Abstract:Objective To assess the value of 99m Tc TRODAT 1 SPECT in diagnosis of early Parkinson's disease(PD). Methods Twenty two patients of early idiopathic PD were studied with 99m Tc TRODAT 1 SPECT. For all patients, the PD was stage 1.5 or less as assessed by the new Hoehn and Yahr scale. Six age matched healthy volunteers (4 men, 2 women) served as controls. 99m Tc TRODAT 1 was prepared from a lyophilized kit. Brain imaging was performed on a dual head camera between 2 ～ 4 h after injection of 1 110 MBq (30mCi) 99m Tc TRODAT 1. Mean counts per pixel were measured manually in the region below the basal ganglia (BG) and normalized to the mean background counts to give specific uptake values (BG/OC). Logistic discriminant analyses were performed to determine the optimum uptake value for differentiating the patients from the controls. Results Quantitative imaging analysis showed that in the Hoehn and Yahn 1 PD and 1.5 PD groups mean the BG/OC (1.40±0.15, 1.20±0.17 respectively)value were less than those in the controls (1.55±0.12) ( P 0.01, P 0.001 respectively). The mean values of specific BG uptake contralateral to the more affected limbs were significantly decreased compared with the ipsilateral sides in both stage 1 and 1.5 groups (1.34±0.13 vs 1.45±0.18, P 0.01, for stage 1 and 1.17±0.16 vs 1.23±0.18, P 0.01, for stage 1.5). No remarkable adverse reactions were found either in the patients or the controls during or after imaging. Conclusion 99m Tc TRODAT 1 SPECT and basal ganglia uptake may serve as a useful imaging method for early detection of Parkinson's disease.